Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Rang în acțiuni #33689
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Preț acțiune
$4.70
Ultima sincronizare: 2026-08-14
Capitalizare de piață
$7.09M
Schimbare (1 zi)
-0.21%
Schimbare (1 an)
-70.63%
Țară
US
Tranzacționează Apimeds Pharmaceuticals US, Inc (APUS)

Categorie

Prețul APUS cu capitalizarea de piață a B
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
APUS
$4.70
Capitalizarea de piață a Apimeds Pharmaceuticals US, Inc(APUS)
Capitalizare de piață: $7.09M
În anul August 2026, Apimeds Pharmaceuticals US, Inc are o capitalizare de piață de $7.09M. Acest lucru face ca Apimeds Pharmaceuticals US, Inc să fie a 33689th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Apimeds Pharmaceuticals US, Inc din 2025 până în 2026
APUS în comparație cu top 5 cele mai populare stocks
Prețul pentru APUS Activul B Capitalizarea de piață a B Rezultate
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
$3,612,485 $7.09M
$5.452T +76,861,285.15%
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
$2,975,151 $7.09M
$4.490T +63,300,989.91%
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
$2,758,070 $7.09M
$4.162T +58,682,242.40%
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
$2,435,997 $7.09M
$3.676T +51,829,618.92%
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc
$1,877,214 $7.09M
$2.833T +39,940,630.60%